QT
AKCA

Quantbot Technologies’s Akcea Therapeutics Inc AKCA Stock Holding History

Quantbot Technologies’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-20
Closed – – 1775
2020
Q2 		$0 Buy
+20
New +$309 ﹤0.01% 1571
2020
Q1 		– Sell
-13,957
Closed -$236K – 1596
2019
Q4 		$236K Buy
+13,957
New +$260K 0.02% 619
2018
Q4 		– Sell
-2,313
Closed -$81K – 1587
2018
Q3 		$81K Sell
2,313
-3,438
-60% -$104K 0.01% 935
2018
Q2 		$136K Buy
5,751
+1,662
+41% +$39.7K 0.01% 812
2018
Q1 		$104K Buy
+4,089
New +$88K 0.01% 841

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quantbot Technologies's AKCA Position: Q3 2020 in Review

Quantbot Technologies sold out of Akcea Therapeutics Inc (AKCA) in Q3 2020, closing a stake of 20 shares.

Quantbot Technologies first reported a position in AKCA in Q1 2018 and held it in 5 quarters. The position peaked at $236K in Q4 2019. 98 funds tracked by Wall St. Rank hold AKCA as of Q3 2020.

  • Quantbot Technologies reported no remaining Akcea Therapeutics Inc position as of Q3 2020 after selling out during the quarter.
  • Quantbot Technologies sold 20 Akcea Therapeutics Inc shares in Q3 2020.
  • Quantbot Technologies first reported a position in Akcea Therapeutics Inc in Q1 2018 and held it in 5 quarters.
  • Quantbot Technologies's Akcea Therapeutics Inc position peaked at $236K in Q4 2019.
  • 98 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q3 2020.

Based on Quantbot Technologies's 13F filing for Q3 2020, filed 16 Nov 2020.